176 related articles for article (PubMed ID: 10469863)
1. Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement.
Wong TY; Chan JC; Szeto CC; Leung CB; Li PK
Am J Kidney Dis; 1999 Sep; 34(3):514-20. PubMed ID: 10469863
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of serum ACE activity on outcome of type 2 diabetic patients on chronic ambulatory peritoneal dialysis.
Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
Am J Kidney Dis; 2002 May; 39(5):1054-60. PubMed ID: 11979350
[TBL] [Abstract][Full Text] [Related]
3. Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis.
Wu MS; Yu CC; Wu CH; Haung JY; Leu ML; Huang CC
Perit Dial Int; 1999; 19 Suppl 2():S179-83. PubMed ID: 10406515
[TBL] [Abstract][Full Text] [Related]
4. Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis.
Yu CC; Wu MS; Wu CH; Yang CW; Huang JY; Hong JJ; Fan Chiang CY; Leu ML; Huang CC
Perit Dial Int; 1997; 17(3):262-8. PubMed ID: 9237287
[TBL] [Abstract][Full Text] [Related]
5. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus.
Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG
Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577
[TBL] [Abstract][Full Text] [Related]
6. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
Torun D; Oguzkurt L; Sezer S; Zumrutdal A; Singan M; Adam FU; Ozdemir FN; Haberal M
Perit Dial Int; 2005; 25(6):596-600. PubMed ID: 16411528
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
8. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
Madden MA; Zimmerman SW; Simpson DP
Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis.
Wong TY; Szeto CC; Chow KM; Leung CB; Lam CW; Li PK
Am J Kidney Dis; 2005 Oct; 46(4):713-9. PubMed ID: 16183427
[TBL] [Abstract][Full Text] [Related]
10. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
[TBL] [Abstract][Full Text] [Related]
11. High peritoneal permeability predisposes to hepatic steatosis in diabetic continuous ambulatory peritoneal dialysis patients receiving intraperitoneal insulin.
Nevalainen PI; Kallio T; Lahtela JT; Mustonen J; Pasternack AI
Perit Dial Int; 2000; 20(6):637-42. PubMed ID: 11216552
[TBL] [Abstract][Full Text] [Related]
12. Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRD.
Flynn JT; Kershaw DB; Sedman AB; Smoyer WE; Bunchman TE
Adv Perit Dial; 1998; 14():265-8. PubMed ID: 10649738
[TBL] [Abstract][Full Text] [Related]
13. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
[TBL] [Abstract][Full Text] [Related]
14. Establishing HbA1c -mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysis.
Zhao C; Luo Q; He F; Peng F; Xia X; Huang F; Yu X
Diabet Med; 2014 Jul; 31(7):813-20. PubMed ID: 24628621
[TBL] [Abstract][Full Text] [Related]
15. Importance of dialysis adequacy in mortality and morbidity of chinese CAPD patients.
Szeto CC; Wong TY; Leung CB; Wang AY; Law MC; Lui SF; Li PK
Kidney Int; 2000 Jul; 58(1):400-7. PubMed ID: 10886588
[TBL] [Abstract][Full Text] [Related]
16. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
[TBL] [Abstract][Full Text] [Related]
17. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A
Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186
[TBL] [Abstract][Full Text] [Related]
18. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
[No Abstract] [Full Text] [Related]
20. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
